CNAP - Centre for Novel Agricultural Products

The project’s most promising plant lines are being extensively tested for their yield, robustness and resistance to pests and diseases at field trial sites in China, East Africa, Madagascar and India. These trials enable us to assess our hybrids under a range of climatic conditions and find those most capable of performing well in the main regions of commercial cultivation.

Early results are promising and demonstrate that some lines can significantly outperform
the current market leader, Artemis.

Field trial partners

Our partners for this work are local artemisinin-producing companies, with extensive grower networks, experience with botanical extraction and good links to the ACT supply chain.

Afroalpine Pharma ltd (Uganda)
AVT Natural Products ltd (India),
Botanical Extracts EPZ ltd (Kenya),
BIONEXX (Madagascar),
Guilin Pharma Company ltd (China),
IPCA Laboratories ltd (India),
PIDI Standard Holdings ltd(China) .

The Swiss not-for-profit organisation, Mediplant is also field- testing our plants. We would like to thank our partners for their valuable contribution to the project..